LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 658 | 532 | 3761 | 0.1417 | -0.0809 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 72 | hr | 658 | 519 | 3761 | 0.1381 | -0.0899 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3556 | 3761 | 0.9457 | 0.9560 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3670 | 3761 | 0.9759 | 0.9806 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 3611 | 3761 | 0.9601 | 0.9678 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3341 | 3761 | 0.8883 | 0.9080 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3389 | 3761 | 0.9013 | 0.9190 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 72 | hr | 658 | 457 | 3761 | 0.1215 | -0.1351 |
Hs 578T | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 658 | 3453 | 3761 | 0.9182 | 0.9332 |
Hs 578T | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 658 | 3573 | 3761 | 0.9503 | 0.9597 |
Hs 578T | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 658 | 3526 | 3761 | 0.9373 | 0.9489 |
Hs 578T | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 658 | 3566 | 3761 | 0.9483 | 0.9582 |
Hs 578T | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 658 | 3667 | 3761 | 0.9751 | 0.9800 |
Hs 578T | GSK1904529A | 10 | uM | LJP6 | 72 | hr | 658 | 3670 | 3761 | 0.9757 | 0.9804 |
Hs 578T | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3634 | 3933 | 0.9241 | 0.9397 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3756 | 3933 | 0.9550 | 0.9645 |
Hs 578T | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3557 | 3933 | 0.9042 | 0.9234 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3586 | 3933 | 0.9116 | 0.9294 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3644 | 3933 | 0.9264 | 0.9415 |
Hs 578T | Linsitinib | 10 | uM | LJP5 | 72 | hr | 658 | 3511 | 3933 | 0.8927 | 0.9139 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3861 | 3933 | 0.9815 | 0.9854 |
Hs 578T | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3642 | 3933 | 0.9260 | 0.9412 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3683 | 3933 | 0.9363 | 0.9495 |
Hs 578T | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3717 | 3933 | 0.9451 | 0.9566 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3559 | 3933 | 0.9048 | 0.9235 |